Claritev Corp 8K

Claritev used its March 16, 2026 Investor Day presentation to present its multi‑year growth strategy, AI-enabled product roadmap, and Vision 2030 financial framework, including detailed guidance for fiscal 2026.

Claritev, a healthcare cost management and analytics company (formerly part of the MultiPlan/Viant ecosystem), furnished an Investor Day presentation dated March 16, 2026, outlining its strategy, operating model, and medium‑term financial outlook, including its Vision 2030 plan, expansion across payer, employer, provider, public sector and international verticals, a detailed 2026 innovation roadmap across Claims Intelligence, Network, Payment & Revenue Integrity, and Data Analytics, and specific 2026 financial guidance for revenue of $980 million to $1.0 billion, adjusted EBITDA of $605–615 million, capital spending of $160–170 million, and free cash flow of $0–10 million, while emphasizing its AI-enabled digital transformation, debt refinancing, rebranding to Claritev, and continued investment in proprietary data, networks, and technology to drive profitable growth and operating leverage.

Filing Facts

CIK

1793229

Ticker

-

Form

8K

Source Type

sec

Accession

0001793229-26-000021

Alert Tier

5